用tecovirimat治疗严重的人类mopox病毒感染:一个案例系列
Koray K Demir1, Michaël Desjardins1,2,3, Claude Fortin1,2
1Division of Infectious Diseases, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC.
概括
德科维里马特 (TCV) 似乎耐受性很好,可能会加快严重的mopox病例的恢复. 需要进一步的临床试验来确认TCV.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 抗病毒疗法 抗病毒疗法
背景情况:
- 德科维里马特 (Tecovirimat,TCV,TPOXX®) 是一种针对脊髓灰质炎病毒的抗病毒药物.
- 它在人类mopox (麻疹) 病例中的有效性尚未确定.
- 批准是基于动物研究,需要人类数据.
研究的目的:
- 描述在加拿大成年人中使用TCV的严重mpox.
- 在现实临床环境中评估TCV的疗效和安全性.
主要方法:
- 在加拿大蒙特利尔对9名成人mopox患者的观察研究.
- 患者通过严重疾病的国家库存获得TCV.
- 有证据表明,TCV用于头部/部,生殖尿道或直肠mopox.
主要成果:
- 所有9名患者都康复了,严重症状的中位数在9天内消失.
- 没有报告任何不良事件或早期停止治疗.
- 三分之二的患者接受了针对细菌超级感染的治疗.
结论:
- 似乎TCV耐受性很好,在严重的mpox中可能会加速恢复.
- 同时用于超级感染的治疗可能会影响结果.
- 建议进行受控临床试验,以验证TCV在严重mopox.
相关概念视频
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Retrovirus Life Cycles
46.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.0K
Pneumonia IV: Management
333
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
333


